Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study

Oughton, J.B. orcid.org/0000-0002-2047-804X, Poad, H., Twiddy, M. et al. (14 more authors) (2017) Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study. BMJ Open, 7 (8). e017913.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Keywords: BCG; RCT; feasibility study; high-risk non-muscle invasive bladder cancer; radical cystectomy; surgical trial
Dates:
  • Published: 1 August 2017
  • Published (online): 11 August 2017
  • Accepted: 16 June 2017
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
YORKSHIRE CANCER RESEARCHS388
Depositing User: Symplectic Sheffield
Date Deposited: 15 Sep 2017 12:01
Last Modified: 15 Sep 2017 12:01
Published Version: https://doi.org/10.1136/bmjopen-2017-017913
Status: Published
Publisher: BMJ Publishing Group
Refereed: Yes
Identification Number: https://doi.org/10.1136/bmjopen-2017-017913
Related URLs:

Share / Export

Statistics